August 22, 2014
A New Jersey federal judge on Thursday denied Sandoz Inc. a patent prosecution bar in a suit alleging the company infringed four Chiesi USA Inc. patents for a ready-to-use version of its intravenous high blood pressure drug Cardene, saying that Sandoz had failed to demonstrate cause for imposing the restriction.